Evercore ISI Group Downgrades Twist Bioscience to In-Line, Raises Price Target to $102
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsDowngradesPrice Target
Evercore ISI Group analyst Vijay Kumar downgrades Twist Bioscience (NASDAQ:TWST) from Outperform to In-Line and raises the price target from $66 to $102.
Evercore ISI Group analyst Vijay Kumar downgrades Twist Bioscience (NASDAQ:TWST) from Outperform to In-Line and raises the price target from $66 to $102.